Skip to main content
  • william-fischer-experimental-pill-treat-COVID

    Carolina Research Leads to Effective Experimental Pill to Treat COVID-19

    University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19, a pill developed by the pharmaceutical companies Merck and Ridgeback Biotherapeutics. William Fischer, MD, at the UNC School of Medicine led pivotal clinical trials on the drug molnupiravir. Scientists at the University of North Ca … Continued

  • Turkeisha Brown

    6 Bedtower Earns Gold Beacon of Excellence

    The American Association of Critical-Care Nurses (AACN) has awarded 6 Bedtower (6BT) a gold-level “Beacon Award for Excellence” at UNC Medical Center. The Beacon application unfolds a story of a nursing unit’s continuous pursuit of excellence and often tells a story of resilience. Patient Services Manager Turkeisha Brown, MSN, RN, NE-BC, says the three-year recognition represents … Continued

  • Medicine-Receives-NCTRACS-Pilot-Awards-600x600

    Medicine Researchers Receive NC TraCS Pilot Grant Awards

    NC TraCS recently announced the recipients of new pilot grant awards, and five recipients are from the Department of Medicine. Following is a list of the recipients and their project titles. Andrea Azcarate-Peril, PhD (Associate Professor, Division of Gastroenterology and Hepatology) Project Title: Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults J … Continued

  • suzanne-day-joe-tucker

    Researchers Seek Suggestions for Improving HIV Research Participation Among Youth in Low and Middle-Income Countries

    There are many social, ethical, and legal challenges associated with obtaining consent for young people to participate in HIV research studies. As a result, youth are often excluded from HIV research, resulting in data gaps. Suzanne Day, PhD, MA, and Joe Tucker, MD, from the division of infectious diseases, are seeking to address this gap and encourage participation in a crowdsou … Continued

  • dr-jonathan-parr

    Parr, Senior Author of Study That Shows Plasmodium Falciparum Evolving to Escape Malaria Rapid Diagnostics in Africa

    A major tool against malaria in Africa has been the use of rapid diagnostic tests, which have been part of the “test-treat-track” strategy in Ethiopia, the second most-populated country in Africa. But researchers studying blood samples from more than 12,000 individuals in Ethiopia now estimate these tests missed nearly 10% of malaria cases caused by the parasite Plasmodium falcip … Continued

  • weber-860x574-1-600x400-1.jpeg

    Weber Study of UV Disinfection Technologies Referenced in Market Research News

    A study by David Weber, MD, MPH, which offers key insights on UV disinfection technologies, was referenced in a press release that recognizes the global UV disinfection equipment market is expected to reach $6.73 billion by 2025.  Weber’s study considered the specifics of manual cleaning, disinfection, and polychromatic actions. Weber is professor of medicine in the division of i … Continued

  • david-wohl

    COVID Vaccine Updates Feature David Wohl

    David Wohl, MD, professor of medicine in the division of infectious diseases, was featured in a number of COVID-19 articles the week of September 10-15. NC Reacts to COVID Vaccine Order – News & Observer (September 11, 2021) As political, medical and business leaders in North Carolina show mixed reactions to President Joe Biden’s new COVID-19 mandate, David Wohl, MD, told the … Continued

  • David Weber, MD, MPH

    Durham School Board Will Collect Vaccination Data Before Deciding Whether to Mandate Vaccines for its Employees

    Indyweek covered a recent Durham public school board meeting designed to weigh the pros and cons of requiring mandatory COVID vaccine shots for teachers and staff. The board members opted to develop a plan of action based on data that will indicate what percentage of school employees have already received the vaccine. David Weber, MD, MPH, professor of medicine in the division of … Continued

  • david-wohl

    Governor Cooper Signs Executive Order Aimed to Expand Access to COVID-19 Antibody Treatment

    Governor Roy Cooper signed an executive order expanding access to monoclonal antibody treatments that have the potential to prevent people from dying of COVID-19. The emergency-use treatment is used on high-risk COVID-19 patients who experience symptoms within 10 days of testing positive. This treatment is reported to be similar to what was used on former President Donald Trump w … Continued

  • Wohl-BRII-Biosciences-Credit-WRAL-News

    UNC Antibody Treatment Could Reduce COVID-19 Hospitalizations By Nearly 80%

    Researchers with the University of North Carolina at Chapel Hill are looking into a new treatment for COVID-19. Vice chair of the study, Dr. David Wohl, professor of medicine in the division of infectious diseases, says the monoclonal antibody cocktail is able to attach to the virus and prevent it from hurting people. Watch the report.